Table 2 Clinical and laboratory values, and treatment of flare of the patients
Case number | Age | CRP on last admission prior to flare (mg/dl) | CRP at time of flare (mg/dl) | ESR on last admission prior to flare (mm/h) | ESR at time of flare (mm/h) | cJADAS − 27 on last admission prior to flare | cJADAS-27 at time of flare | Treatment |
|---|---|---|---|---|---|---|---|---|
1 | 7 | 0,09 | 0,83 | 7 | 11 | 1 | 3 | IACSI, NSAID |
2 | 17 | 0,02 | 0,2 | 2 | 18 | N/A | 7 | methylprednisolone pulses × 3 |
3 | 9 | < 0,06 | 0,11 | 10 | 10 | 1 | 15 | methylprednisolone pulses × 3 |
4 | 17 | 0,35 | 18,11 | 3 | 73 | 6 | 20 | methylprednisolone pulses × 3, IACSI, addition of methotrexate |
5 | 15 | 0 | 0,22 | 5 | 31 | 1 | 10 | methylprednisolone pulses × 3, IACSI, switch from golimumab to abatacept |